A user friendly microplate Analyser with the special filters for up to 6 standard wavelengths and integrated analysis software. It is designed for in vitro diagnostic use to measure and interpret ELISA test results, both monochromatically and bichromatically.
It is intended to be used for intensity measurements on a large number of samples, as well as a very small volume of samples, in laboratories, pathology departments, blood banks and Hospitals for the study of antigen and antibody detection and quantization using microplate technique.
Product category: Thyroid function hormones, Diagnostic agents / kits for thyroid gland, etc. determination (Thyroid function hormones)
Free T4 ELISA Test CE
The RecombiLISA Free T4 ELISA Test is a competitive solid-phase enzyme-linked immunosorbent assay. The two main kit components are:
A 96-well breakable microplate pre-coated with anti-fT4 antibody; A liquid conjugate solution composed of horseradish peroxidase with T4 (HRP-T4 conjugate) This test is intended for the quantitative determination of free thyroxine (fT4) level in human serum. It is intended to be used by professionals as an aid in the diagnosis of thyroid dysfunction. Any interpretation or use of this test result must also rely on other clinical findings as well as on the professional judgment of health care providers.
Recommended for use:
aid in diagnosis of hyper- and hypothyroidism distinguish between different thyroid disorders aid in diagnose of pituitary disorder and female infertility monitor patients undergoing treatment for thyroid disorder, pituitary disease, and thyroid cancer Quantitative measurement of the more stable fT4/fT3 levels is believed to be more accurate in most cases. In a normal thyroid testing algorithm, ft4 tests are usually ordered after TSH levels are measured in the blood.
If fT4 levels are abnormal, a diagnosis can be made depending on the combination of TSH and fT4 levels. For example, low TSH and high fT4 levels normally indicate hyperthyroidism, but high TSH and low fT4 levels may indicate hypothyroidism.
The OnSite HCG Urine Rapid Test is a lateral flow chromatographic immunoassay for the early detection of pregnancy, by providing a quick direct visual test for the placental hormone, hCG, at the cut-off level of 25 mIU hCG/mL of human urine.
The Hepatitis C Virus (HCV) is a small, enveloped, and single-stranded RNA virus that causes hepatitis C disease in the liver. The virus can cause both acute and chronic hepatitis infection, ranging in severity from a mild illness lasting a few weeks to a serious, lifelong illness. A significant number of those who are chronically infected will develop liver cirrhosis or liver cancer, as there is currently no vaccine for hepatitis C.
The virus contains structure proteins, including core, E, and 6 nonstructural (NS) proteins. The core, NS3, 4 and 5 are the key antigens utilized in the 3rd generation of HCV antibody test.
A7289 is a fusion antigen composed of HCV core-NS3-NS4-NS5 immunodominant domains. It is expressed in E. coli and purified with affinity chromatography.
The OnSite Syphilis Ab Combo Rapid Test is a lateral flow chromatographic immunoassay for the qualitative detection of antibodies (IgG, IgM and IgA) to Treponema pallidum (Tp) in human serum, plasma or whole blood.
Simplifying diagnostics. Improving global health. Located in San Diego, California, an area well known for biotechnology and scientific discovery, CTK Biotech develops and manufactures innovative immunodiagnostic tools and point of care diagnostic test kits for the IVD community worldwide. Our IVD products allow medical professionals to quickly and accurately diagnose disease and meet patient needs. The simplicity and portability of our test kits make them ideally suited for use in a wide range of settings including remote locations and countries with large populations where complicated medical diagnostics are not readily available.
CTK Biotech is focused on quality and strives to stay ahead of changing market conditions. With top notch experts at the helm, we identify and adopt new technologies, plan for upcoming trends and achieve commercialization as a result of our advances. CTK invests heavily in research to develop new products in response to market demands and continuously improve our point of care tests. For each step of product development we have established a proficient pathway to convert scientific discoveries and the latest technologies into diagnostic solutions for use in the real world.
We have a unique business model in that we produce our own recombinant antigens and antibodies for later use in the production of our test kits. Our skill in raw material identification, generation and purification gives us an edge over our competitors as we can guarantee excellent control over quality, supply and consistency between lots to ensure that our customers receive the highest quality products at exceptional pricing.
Customer service is an equally important factor to our business. We strive to obtain and retain our loyal customers by exceeding their expectations with unparalleled service and creating sustainable value. From navigating the regulatory environment to regular communication from the time of order to deliver, CTK is known for excellence in quality and service.